Understanding Stevens-Johnson Syndrome: A Rare but Life-Threatening Condition
Stevens-Johnson syndrome (SJS) is a rare and potentially life-threatening immune reaction that affects both the skin and mucous membranes. It often begins with symptoms like fever, fatigue, and burning eyes, followed by painful rashes that can spread rapidly across the body. In severe cases, the skin may blister and peel off, resembling second-degree burns. This condition can be triggered by medications, making it a critical concern for public health.
The Story of Bibilomo George and Her Father
For Bibilomo George, founder of Posh Accent Academy in Lagos State, what started as a simple cough in her late father, Babalola Olalekan, quickly turned into a life-threatening ordeal. Olalekan, a 70-year-old widower who had raised his four children alone, sought treatment from a nearby pharmacy he trusted in Abule Egba. Unbeknownst to him, the medication he was given would trigger a severe reaction.
The initial changes in his appearance were subtle, but they soon became alarming. George noticed that her father was getting darker and kept asking, “Daddy, why are you dark?” Despite her growing concern, Olalekan reassured her, choosing to conceal his discomfort to remain strong for his children.
The situation took a critical turn when physical symptoms became obvious. George described how she noticed his skin peeling off, realizing something was seriously wrong. The family then embarked on a desperate search for medical help, moving from one hospital to another, only to face repeated rejections.
Eventually, they secured admission to a hospital in Surulere, but only after being asked to make a substantial deposit. After a series of tests, doctors diagnosed Pa Olalekan with Stevens-Johnson syndrome, a condition the family had never encountered before. By then, the illness had taken a severe toll on his body, leaving him unable to sit, eat, or care for himself.
The Hidden Dangers in Common Drugs
Dr Frederick Unuigbokhai, a company physician at Aim Group of Companies, described SJS as an extremely rare, severe, and unpredictable immune reaction. He noted that the condition is so uncommon that, even in a population of 200 million, only a few hundred cases might occur. According to Unuigbokhai, while there are four main causes of SJS, medications are the most frequent triggers in this part of the world.
He emphasized that reactions are not always predictable, even if a person has taken the same medication before. Common triggers include sulfur-containing drugs such as Fansidar and Halfan, anti-convulsants, acetaminophen, erythromycin, ciprofloxacin, and penicillins. Antiretroviral drugs for people living with HIV can also cause the syndrome.
Unuigbokhai stressed the importance of knowing one’s history of drug reactions, adding that early awareness and caution can be lifesaving. He warned that even if a person has taken a medication before without issues, they could react severely the next time.
The Impact on Families and Survivors
Mistura Afolabi, a survivor of SJS, described how a minor discomfort turned into a life-threatening ordeal after an attempt to treat an allergy. She recalled that the rash started after eating shawarma and worsened rapidly, leading to difficulty breathing and other severe symptoms. A student nurse recognized the danger and advised proper treatment, but the hospital initially refused admission.
Afolabi’s experience highlights the challenges faced by those affected by SJS. She lost almost all vision and could eat only liquids through a straw, each sip burning painfully. It took nearly two months for her to walk again and nearly three months to regain her sight. Full recovery took about two years of treatment, and she now uses glasses due to myopic astigmatism.
Stephen Opara, a 19-year-old from Imo State, recalls a childhood illness that began as a simple fever and left lasting lessons. At six years old, he developed mouth sores, skin and lip peeling, and painful blisters. His family initially believed it was malaria, but after multiple tests and consultations, it was confirmed that he had SJS.
The High Mortality Rate and Complications
Dr Casmir Ifeanyi, National President of the Association of Medical Laboratory Scientists of Nigeria, warned that SJS carries a high risk of death, with about five to 10 per cent of affected patients unlikely to survive. He explained that the condition can lead to severe complications, including respiratory failure and infections such as mycoplasma pneumoniae, which can be fatal. Survivors may experience blindness, skin damage, and chronic pain.
Tahir Laurat, a Registered Community Health Practitioner in Lagos State, warned that if SJS is not properly managed, it can escalate into Toxic Epidermal Necrolysis, a more dangerous condition that can be fatal. She cautioned that the condition cannot be treated at home and often requires hospitalisation and intensive care.
Psychological and Emotional Challenges
Jacob Micheal, a Psychotherapist and Emotional Intelligence expert, highlighted the psychological and emotional challenges faced by survivors of SJS. He explained that the immediate experience of the illness can be traumatic, leaving patients overwhelmed by fear, confusion, and helplessness. Many feel helpless, anxious, and mentally overwhelmed, with the psychological impact often including depression and loss of trust in one’s body.
The emotional toll also affects family members and caregivers, who may experience fear, anxiety, and exhaustion while supporting their loved ones. Even after recovery, anxiety doesn’t just switch off; they may remain hyper-alert about the survivor’s health.
The Strain on the Healthcare System
Damilola Fajinmi, a public health expert, cautioned that the country’s health system is not prepared to detect and manage SJS. She noted that the condition exposes critical weaknesses in drug safety systems and emergency response structures. Many patients unknowingly trigger SJS after taking routine medications, and delays in diagnosis persist due to limited clinical experience.
James Odubia, another public health expert, recommended better public education, stricter drug regulation, improved detection, and wider access to specialised care as key preventive measures. He called for better training of healthcare workers to recognize early signs and act promptly.
Sowunmi Ayorinde, a Pharmacist, urged Nigerians to seek prompt medical attention at the first signs of unusual reactions following drug use. He called for stronger collaboration among healthcare workers, public health specialists, and policymakers to boost health education and promote rational drug use nationwide.
